Menu Menu

ALRN    Aileron Therapeutics Inc    1420565    
Income Statement
Net Income -5,847,000

Balance Sheet
Current Assets 18,684,000
Assets 104,217,000
Current Liabilities 5,659,000
Liabilities 104,217,000
Shares Out 21,666,000

Cash Flow Statement
Operating Cash Flow -17,479,000

Market Analysis
Market Cap 61,747,499
PB 14.75
EPS -3.25
PS 37237.62
FCF -17,479,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view ALRN documents filed with the SEC.


ALRN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: